Sibel Naycı

803 total citations
17 papers, 193 citations indexed

About

Sibel Naycı is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Sibel Naycı has authored 17 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 4 papers in Emergency Medical Services. Recurrent topics in Sibel Naycı's work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Asthma and respiratory diseases (5 papers) and Pediatric health and respiratory diseases (4 papers). Sibel Naycı is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Asthma and respiratory diseases (5 papers) and Pediatric health and respiratory diseases (4 papers). Sibel Naycı collaborates with scholars based in Türkiye, United States and United Kingdom. Sibel Naycı's co-authors include Eylem Sercan Özgür, Mehmet Polatlı, Nurdan Köktürk, Cengiz Özge, Nilgün Yılmaz Demirci, Arzu Yorgancıoğlu, Ömer Aydemır, Gamze Kırkıl, Ahmet Ïlvan and Bahar Taşdelen and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and BMC Health Services Research.

In The Last Decade

Sibel Naycı

15 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sibel Naycı Türkiye 5 171 76 26 19 15 17 193
Paula Almeida Brazil 8 140 0.8× 150 2.0× 8 0.3× 5 0.3× 7 0.5× 16 197
Minna Tommola Finland 7 225 1.3× 237 3.1× 11 0.4× 14 0.7× 5 0.3× 14 297
Anna Murphy United Kingdom 7 298 1.7× 313 4.1× 31 1.2× 17 0.9× 4 0.3× 21 374
Nicole Filipow Canada 6 218 1.3× 88 1.2× 12 0.5× 5 0.3× 17 1.1× 12 271
Camilla Boslev Bårnes Denmark 3 224 1.3× 267 3.5× 27 1.0× 8 0.4× 2 0.1× 6 303
Claire Houghton New Zealand 5 254 1.5× 275 3.6× 10 0.4× 9 0.5× 2 0.1× 8 311
Pei Z. Li Canada 6 270 1.6× 97 1.3× 12 0.5× 13 0.7× 3 0.2× 8 307
Rosa Palomino Spain 8 264 1.5× 285 3.8× 22 0.8× 7 0.4× 6 0.4× 10 389
J.M. Kouwenberg Netherlands 11 260 1.5× 229 3.0× 18 0.7× 33 1.7× 2 0.1× 15 329
Ovcharenko Si Russia 8 271 1.6× 137 1.8× 10 0.4× 35 1.8× 3 0.2× 58 326

Countries citing papers authored by Sibel Naycı

Since Specialization
Citations

This map shows the geographic impact of Sibel Naycı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibel Naycı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibel Naycı more than expected).

Fields of papers citing papers by Sibel Naycı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibel Naycı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibel Naycı. The network helps show where Sibel Naycı may publish in the future.

Co-authorship network of co-authors of Sibel Naycı

This figure shows the co-authorship network connecting the top 25 collaborators of Sibel Naycı. A scholar is included among the top collaborators of Sibel Naycı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibel Naycı. Sibel Naycı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Öztürk, Ebru, et al.. (2024). Physicians’ irrational attitudes on the antibiotic prescribing for the treatment of COVID-19 in Turkey: A multicenter survey. BMC Health Services Research. 24(1). 650–650. 1 indexed citations
2.
Günen, Hakan, Nurdan Köktürk, Sibel Naycı, et al.. (2022). The CO-MIND Study: Chronic Obstructive Pulmonary Disease Management in Daily Practice and Its Implications for Improved Outcomes According to GOLD 2019 Perspective. International Journal of COPD. Volume 17. 1883–1895. 2 indexed citations
3.
Köktürk, Nurdan, Alev Gürgün, Elif Şen, et al.. (2017). The View of the Turkish Thoracic Society on the Report of the GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of COPD. Turkish Thoracic Journal. 18(2). 57–64. 20 indexed citations
4.
Naycı, Sibel, Eylem Sercan Özgür, & Cengiz Özge. (2016). Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease. PA3683–PA3683. 1 indexed citations
5.
Naycı, Sibel, et al.. (2016). Effectiveness of Omalizumab Treatment in Asthma-COPD Overlap Syndrome. CHEST Journal. 150(4). 867A–867A.
6.
Naycı, Sibel, Lütfi Çöplü, Alev Gürgün, et al.. (2015). Updates in Chronic Obstructive Pulmonary Disease for the Year 2014. Turkish Thoracic Journal. 16(2). 86–96. 1 indexed citations
7.
Naycı, Sibel, et al.. (2014). Impact of Comorbidities on COPD Assessment Test (CAT) Scores. CHEST Journal. 145(3). 431D–431D. 1 indexed citations
8.
Özge, Cengiz, Lülüfer Tamer, Hatice Kalkan Yı̇ldırım, et al.. (2014). The Relation of Weight Loss with Hyperinflation, Serum Adiponectin, Ghrelin and Leptin Levels in Chronic Obstructive Pulmonary Disease. Eurasian Journal of Pulmonology. 16(1). 21–26. 1 indexed citations
9.
Naycı, Sibel, et al.. (2013). The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation. European Respiratory Journal. 42(Suppl 57). P3652–P3652.
10.
Özgür, Eylem Sercan, Cengiz Özge, Ahmet Ïlvan, & Sibel Naycı. (2013). Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma. Journal of Asthma. 50(6). 687–694. 23 indexed citations
11.
Polatlı, Mehmet, Arzu Yorgancıoğlu, Ömer Aydemır, et al.. (2013). [Validity and reliability of Turkish version of St. George's respiratory questionnaire].. PubMed. 61(2). 81–7. 66 indexed citations
12.
Yorgancıoğlu, Arzu, Mehmet Polatlı, Ömer Aydemır, et al.. (2012). Reliability and validity of Turkish version of COPD assessment test. Tuberkuloz ve Toraks. 60(4). 314–320. 52 indexed citations
13.
Özgür, Eylem Sercan, Sibel Naycı, Cengiz Özge, & Bahar Taşdelen. (2012). An Integrated Index Combined by Dynamic Hyperinflation and Exercise Capacity in the Prediction of Morbidity and Mortality in COPD. Respiratory Care. 57(9). 1452–1459. 20 indexed citations
14.
Özgür, Eylem Sercan, Cengiz Özge, Ahmet Ïlvan, & Sibel Naycı. (2012). Assesment of long-term omalizumab treatment in severe allergic asthma. 40. 225. 1 indexed citations
15.
Özgür, Eylem Sercan, et al.. (2012). Ruptured Pulmonary Hydatid Cyst Diagnosed by Bronchoscopy. 1(2). 51–54. 1 indexed citations
16.
Özgür, Eylem Sercan, Cengiz Özge, Ahmet Ïlvan, & Sibel Naycı. (2012). Relationship between quality of life and multidimensional assessment indices in patients with COPD. 40. 727. 2 indexed citations
17.
Özgür, Eylem Sercan, et al.. (2011). Does anatomic location of deep venous thrombosis affect the clinical findings and course in the patient of pulmonary embolism. European Respiratory Journal. 38(Suppl 55). p2345–p2345. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026